These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34774285)

  • 1. 3-Month Enalapril Treatment in Pediatric Fontan Patients With Moderate to Good Systolic Ventricular Function.
    Harteveld LM; Blom NA; Terol Espinosa de Los Monteros C; Kuipers IM; Rammeloo LAJ; Hazekamp MG; van Dijk JG; Ten Harkel ADJ
    Am J Cardiol; 2022 Jan; 163():98-103. PubMed ID: 34774285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril does not enhance exercise capacity in patients after Fontan procedure.
    Kouatli AA; Garcia JA; Zellers TM; Weinstein EM; Mahony L
    Circulation; 1997 Sep; 96(5):1507-12. PubMed ID: 9315539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthostatic stress response in pediatric Fontan patients and the effect of ACE inhibition.
    Harteveld LM; Blom NA; van Dijk JG; Reijntjes RH; van Someren PJ; Kerkhof FI; Kuipers IM; Rammeloo LAJ; de Geus EJC; Ten Harkel ADJ
    PLoS One; 2022; 17(9):e0273940. PubMed ID: 36048833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure.
    McCrindle BW; Zak V; Sleeper LA; Paridon SM; Colan SD; Geva T; Mahony L; Li JS; Breitbart RE; Margossian R; Williams RV; Gersony WM; Atz AM;
    Circulation; 2010 Jan; 121(1):34-42. PubMed ID: 20026781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-brain natriuretic peptide serum levels reflect attrition of the Fontan circulation.
    Wolff D; van Melle JP; Willems TP; Bartelds B; Ploegstra MJ; Hillege H; Ebels T; Berger RMF
    Cardiol Young; 2020 Jun; 30(6):753-760. PubMed ID: 32513314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure.
    Rosenberg J; Gustafsson F; Remme WJ; Riegger GA; Hildebrandt PR
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):305-11. PubMed ID: 18309461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
    McMurray JJ; Packer M; Desai AS; Gong J; Lefkowitz MP; Rizkala AR; Rouleau J; Shi VC; Solomon SD; Swedberg K; Zile MR;
    Eur J Heart Fail; 2013 Sep; 15(9):1062-73. PubMed ID: 23563576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.
    Patten RD; Kronenberg MW; Benedict CR; Udelson JE; Kinan D; Stewart D; Yusuf S; Smith JJ; Kilcoyne L; Dolan N; Edens TR; Metherall J; Konstam MA
    Am Heart J; 1997 Jul; 134(1):37-43. PubMed ID: 9266781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
    J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure.
    Brunner-La Rocca HP; Weilenmann D; Kiowski W; Maly FE; Candinas R; Follath F
    Am Heart J; 1999 Oct; 138(4 Pt 1):654-62. PubMed ID: 10502210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.
    Schuuring MJ; Vis JC; van Dijk AP; van Melle JP; Vliegen HW; Pieper PG; Sieswerda GT; de Bruin-Bon RH; Mulder BJ; Bouma BJ
    Eur J Heart Fail; 2013 Jun; 15(6):690-8. PubMed ID: 23361871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of enalapril+losartan treatment with cardiopulmonary exercise test in patients with left ventricular dysfunction.
    Akbulut T; Akgöz H; Dayi SU; Celik SE; Gürkan U; Tayyareci G
    Angiology; 2006; 57(2):181-6. PubMed ID: 16518525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years.
    Robbers-Visser D; Kapusta L; van Osch-Gevers L; Strengers JL; Boersma E; de Rijke YB; Boomsma F; Bogers AJ; Helbing WA
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):89-95. PubMed ID: 19577062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.
    Kostova E; Jovanoska E; Zafirov D; Jakovski K; Maleska V; Slaninka-Miceska M
    Bratisl Lek Listy; 2005; 106(12):407-11. PubMed ID: 16642666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators.
    Dunselman PH;
    Int J Cardiol; 2001 Feb; 77(2-3):131-8; discussion 139-40. PubMed ID: 11182175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.